Literature DB >> 15249290

The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs?

David Wendler1, Ezekiel J Emanuel, Reidar K Lie.   

Abstract

To avoid exploitation of host communities, many commentators argue that subjects must receive the best methods available worldwide. Others worry that this requirement may block important research intended to improve health care, especially in developing countries. To resolve this dilemma, we propose a framework for the conditions under which it is acceptable to provide subjects with less than the best methods. Specifically, institutional review boards should assume a default of requiring the "worldwide best" methods, meaning the best methods available anywhere in the world, in all cases.However, institutional review boards should be willing to grant exceptions to this default for research studies that satisfy the following 4 conditions: (1) scientific necessity, (2) relevance for the host community, (3) sufficient host community benefit, and (4) subject and host community non-maleficence.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 15249290      PMCID: PMC1448364          DOI: 10.2105/ajph.94.6.923

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  35 in total

1.  HIVNET nevirapine trials.

Authors:  P Lurie; S M Wolfe
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

2.  Investigators' responsibilities for human subjects in developing countries.

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

3.  Improving the health of the global poor.

Authors:  Prabhat Jha; Anne Mills; Kara Hanson; Lilani Kumaranayake; Lesong Conteh; Christoph Kurowski; Son Nam Nguyen; Valeria Oliveira Cruz; Kent Ranson; Lara M E Vaz; Shengchao Yu; Oliver Morton; Jeffrey D Sachs
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

4.  6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

Authors:  F Dabis; P Msellati; N Meda; C Welffens-Ekra; B You; O Manigart; V Leroy; A Simonon; M Cartoux; P Combe; A Ouangré; R Ramon; O Ky-Zerbo; C Montcho; R Salamon; C Rouzioux; P Van de Perre; L Mandelbrot
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

Review 5.  Science, ethics, and the future of research into maternal infant transmission of HIV-1. Perinatal HIV Intervention Research in Developing Countries Workshop participants.

Authors: 
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

6.  Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

Authors:  S Z Wiktor; E Ekpini; J M Karon; J Nkengasong; C Maurice; S T Severin; T H Roels; M K Kouassi; E M Lackritz; I M Coulibaly; A E Greenberg
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

7.  Defining and refining international donor support for combating the AIDS pandemic.

Authors:  A Attaran; J Sachs
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

8.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

9.  Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Authors:  E Marseille; J G Kahn; F Mmiro; L Guay; P Musoke; M G Fowler; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

10.  A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.

Authors:  M Lallemant; G Jourdain; S Le Coeur; S Kim; S Koetsawang; A M Comeau; W Phoolcharoen; M Essex; K McIntosh; V Vithayasai
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

View more
  22 in total

1.  The standard of care debate: conceptual clarifications.

Authors:  Adnan A Hyder
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

2.  The definition of adequate care in externally sponsored clinical trials: the terminological controversy about the concept "standard of care".

Authors:  Hans-Jörg Ehni
Journal:  Sci Eng Ethics       Date:  2006-01       Impact factor: 3.525

3.  Justice and fairness in the Kennedy Krieger Institute lead paint study: the ethics of public health research on less expensive, less effective interventions.

Authors:  David R Buchanan; Franklin G Miller
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

4.  Sharing benefits in international health research. Research-capacity building as an example of an indirect collective benefit.

Authors:  Annette Schulz-Baldes; Effy Vayena; Nikola Biller-Andorno
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

5.  Ethical review issues in collaborative research between us and low-middle income country partners: a case example.

Authors:  Scott McIntosh; Essie Sierra; Ann Dozier; Sergio Diaz; Zahira Quiñones; Aron Primack; Gary Chadwick; Deborah J Ossip-Klein
Journal:  Bioethics       Date:  2008-06-28       Impact factor: 1.898

6.  Human rights, cultural pluralism, and international health research.

Authors:  Patricia A Marshall
Journal:  Theor Med Bioeth       Date:  2005

7.  Is There Ever a Role for the Unilateral Do Not Attempt Resuscitation Order in Pediatric Care?

Authors:  Jonathan M Marron; Emma Jones; Joanne Wolfe
Journal:  J Pain Symptom Manage       Date:  2017-09-13       Impact factor: 3.612

8.  Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.

Authors:  Diana I Pérez-Román; Ana B Ortiz-Haro; Emmanuel Ruiz-Medrano; Irazú Contreras-Yáñez; Virginia Pascual-Ramos
Journal:  Rheumatol Int       Date:  2017-12-20       Impact factor: 2.631

9.  The investigator and the IRB: a survey of depression and schizophrenia researchers.

Authors:  Bernard A Fischer; Praveen George
Journal:  Schizophr Res       Date:  2010-01-12       Impact factor: 4.939

10.  Gradations of researchers' obligation to provide ancillary care for HIV/AIDS in developing countries.

Authors:  Henry S Richardson
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.